Patents by Inventor Gert Hoy Talbo

Gert Hoy Talbo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKERS OF ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF
    Publication number: 20160053318
    Abstract: The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions.
    Type: Application
    Filed: September 4, 2015
    Publication date: February 25, 2016
    Applicant: Medvet Science Pty Ltd.
    Inventors: CLAUDINE SHARON BONDER, Angel Francisco Lopez, Gert Hoy Talbo
  • Markers of Endothelial Progenitor Cells and Uses Thereof
    Publication number: 20130224116
    Abstract: The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions.
    Type: Application
    Filed: November 7, 2011
    Publication date: August 29, 2013
    Applicant: TransBio Ltd.
    Inventors: Claudine Sharon Bonder, Angel Fransciso Lopez, Gert Hoy Talbo
  • Method of producing an anticoagulation effect
    Patent number: 7456148
    Abstract: A method for producing an anticoagulation effect in a blood coagulation assay, said method comprising contacting a sample of blood with an effective amount of apolipoprotein CIII or fragment, derivative, homologue, analogue, chemical equivalent, functional equivalent or mimetic thereof.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: November 25, 2008
    Assignee: Healthlinx Limited
    Inventors: Dominic J. Autelitano, Michael C. Berndt, Antonio Rajic, A. Ian Smith, Gert Hoy Talbo
  • Antimicrobial peptides
    Publication number: 20030195150
    Abstract: The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEA&Sgr;PEVIESPPE (SEQ ID NO:3), AVESTVATLED&Sgr;PEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein.
    Type: Application
    Filed: October 24, 2002
    Publication date: October 16, 2003
    Inventors: Eric Charles Reynolds, Stuart Geoffrey Dashper, Neil Martin O'Brien-Simpson, Gert Hoy Talbo, Marina Malkoski